Companies: 10,795·Total market cap: $144.5T
CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation

CAMPNASDAQHealthcare● Active
$4.23
+$0.14(+3.30%)
Market Cap$89739942
P/E Ratio
52W High$7.75
52W Low$1.305
Overview

CAMP4 Therapeutics Corporation (CAMP) Revenue

Annual & quarterly revenue history · segment & region breakdown

CAMP · revenue · updated Jun 9, 2026

Core revenue metrics

CAMP4 Therapeutics Corporation trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
21.92×
mktCap ÷ TTM rev
Revenue per day
$0M
Est. TTM ÷ 365
Revenue / employee
$72K
55 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · CAMP4 Therapeutics Corporation SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
CAMP revenue by year · CAMP revenue history · CAMP annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income CAMP4 Therapeutics Corporation receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

CAMP4 Therapeutics Corporation reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from CAMP4 Therapeutics Corporation's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

CAMP revenue · 4 questions

CAMP's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

CAMP revenueCAMP annual revenuewhat is CAMP revenueCAMP TTM revenue

Source: FMP · CAMP4 Therapeutics Corporation SEC filings · GAAP · CAMP4 Therapeutics Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026